https://www.selleckchem.com/products/ag-825.html
Certain disease modifying therapies may negatively impact the humoral response to SARS-CoV-2 vaccines. Many MS related clinical, demographic, and immunological characteristics can also affect vaccine response but those have not been fully explored. This study aimed to investigate potential correlations between clinical, demographic, and immunological variables in MS patients to post-vaccination spike protein antibody positivity rates and levels. Patients with MS and related neuroimmunological disorders who requested verification of the i
Like
Comment
Share
